Rigel Pharmaceuticals
RIGL
#7137
Rank
ยฃ0.36 B
Marketcap
ยฃ19.62
Share price
-2.44%
Change (1 day)
27.72%
Change (1 year)

Earnings for Rigel Pharmaceuticals (RIGL)

Earnings in 2025 (TTM): ยฃ91.03 Million

According to Rigel Pharmaceuticals's latest financial reports the company's current earnings are ยฃ0.28 Billion. In 2024 the company made an earning of ยฃ19.87 Million, an increase over its 2023 earnings that were of -ยฃ13.78 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rigel Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) ยฃ91.03 M358%
2024 ยฃ19.87 M-244.27%
2023 -ยฃ13.78 Million-66.79%
2022 -ยฃ41.5 Million340.73%
2021 -ยฃ9.42 Million-56.15%
2020 -ยฃ21.48 Million-57.34%
2019 -ยฃ50.34 Million-7.66%
2018 -ยฃ54.51 Million-9.47%
2017 -ยฃ60.21 Million24.46%
2016 -ยฃ48.38 Million23.63%
2015 -ยฃ39.13 Million-43.29%
2014 -ยฃ69.01 Million2.5%
2013 -ยฃ67.33 Million
2010 ยฃ28.62 M-133.97%
2009 -ยฃ84.28 Million-18.49%
2008 -ยฃ0.11 Billion71.91%
2007 -ยฃ60.15 Million84.74%
2006 -ยฃ32.56 Million-10.17%
2005 -ยฃ36.25 Million-15.73%
2004 -ยฃ43.01 Million39.29%
2003 -ยฃ30.88 Million10.3%
2002 -ยฃ28 Million48.3%
2001 -ยฃ18.88 Million-2.13%
2000 -ยฃ19.29 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
ยฃ6.23 B 6,662.31%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ9.89 B 10,637.34%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
-ยฃ82.45 Million-189.43%๐Ÿ‡บ๐Ÿ‡ธ USA
ChemoCentryx
CCXI
-ยฃ98.77 Million-207.13%๐Ÿ‡บ๐Ÿ‡ธ USA